**Abstract**

**Objective:** According to previous studies, the cannabinoid receptor 1 (CNR1) gene could be an important candidate gene for schizophrenia which is located on chromosome 6q14-q15. The association between CNR1 polymorphisms and schizophrenia is actively being investigated, and some studies have linked the AAT-trinucleotide repeats in CNR1 gene with the risk of schizophrenia. Meanwhile, smooth pursuit eye movement(SPEM) has been regarded as one of the most consistent endophenotype of schizophrenia.

In this study, we investigated the association between the AAT-trinucleotide repeats in CNR1 gene and smooth pursuit eye movement abnormality in Korean patients with schizophrenia.

**Methods:** We measured SPEM function in 187 Korean patients with schizophrenia (84 male, 83 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated allele frequencies of AAT-repeat polymorphisms on CNR1 gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and AAT-trinucleotide repeats in each group.

**Results:** The natural logarithm value of signal/noise ration(Ln S/N ratio) of good SPEM function group was 4.34 ± 0.29 and that of poor SPEM function group was 3.21 ± 0.70.

In total, 7 types of trinucleotide repeats were identified, each containing 7, 10, 11, 12, 13, 14, and 15 repeats, respectively. (AAT)~13~ allele was most frequently observed, with a frequency of 30.5%. The frequencies of the other repeat alleles (in the decreasing order) were as follows: (AAT)~13~ 30.5%, (AAT)~14~ 24.3%, (AAT)~12~ 19.8%, and (AAT)~7~ 11.1%.

However, no significant associations were found between the number of AAT-repeat polymorphisms of the CNR1 gene and SPEM function.

**Conclusions:** No significant associations were found between AAT-trinucleotide polymorphisms and SPEM abnormality in Korean patients with schizophrenia.
